Literature DB >> 8477016

Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery.

P M Roekaerts1, F J Huygen, S de Lange.   

Abstract

The use and the hemodynamic effects of propofol and midazolam were studied during titrated continuous infusions to deep sedation (sedation level 5: asleep, sluggish response to light glabellar tap or loud auditory stimulus) following coronary artery surgery. The drugs were compared in 30 ventilated patients in an open randomized study. The duration of infusion was approximately 570 minutes in both groups. After a loading dose of propofol (1 mg/kg) or midazolam (0.07 mg/kg), the infusion rates were 2.71 +/- 1.13 mg/kg/h and 0.092 +/- 0.028 mg/kg/h, respectively. An analgesic infusion of sufentanil was also given in both groups. In the midazolam group, to maintain the predetermined level of sedation, more frequent additional bolus doses (4.7 +/- 1.8; P < 0.001) and infusion rate adjustments (5.3 +/- 1.6; P < 0.001) were required than for similar sedation in the propofol group (2.3 +/- 1.0 bolus doses and 3.3 +/- 1.2 adjustments). The time from stopping sedation to patient responsiveness was 11 +/- 8 minutes in the propofol group and 72 +/- 70 minutes in the midazolam group (P < 0.001), and the time from stopping sedation to extubation was 250 +/- 135 minutes and 391 +/- 128 minutes (P < 0.014), respectively. Following the loading dose of propofol, there was a fall in blood pressure (BP) (mean from 80 +/- 11 mmHg to 67.5 +/- 10 mmHg; P < 0.05). After approximately 15 minutes, BP started to rise but remained below pretreatment level throughout sedation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477016     DOI: 10.1016/1053-0770(93)90206-z

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  13 in total

Review 1.  Pain relief following cardiac surgery: a review.

Authors:  A Taylor; D Phelan; J R McCarthy
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

Review 2.  Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.

Authors:  Derek J Roberts; Babar Haroon; Richard I Hall
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

3.  Fast-track practice in cardiac surgery: results and predictors of outcome.

Authors:  Marco C Haanschoten; Albert H M van Straten; Joost F ter Woorst; Pieter S Stepaniak; Auke-Dick van der Meer; André A J van Zundert; Mohamed A Soliman Hamad
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-09-05

Review 4.  The ABCDEF Bundle for the Respiratory Therapist.

Authors:  Matthew F Mart; Nathan E Brummel; E Wesley Ely
Journal:  Respir Care       Date:  2019-11-05       Impact factor: 2.258

5.  Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.

Authors:  A A Weinbroum; P Halpern; V Rudick; P Sorkine; M Freedman; E Geller
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

Review 6.  Propofol: a review of its use in intensive care sedation of adults.

Authors:  Kate McKeage; Caroline M Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 7.  Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.

Authors:  B K Wagner; D A O'Hara
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

8.  Effects of Propofol on Hemodynamic Profile in Adults Receiving Targeted Temperature Management.

Authors:  W Anthony Hawkins; Jennifer Y Kim; Susan E Smith; Andrea Sikora Newsome; Ronald G Hall
Journal:  Hosp Pharm       Date:  2021-07-11

Review 9.  Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.

Authors:  B Fulton; E M Sorkin
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

10.  Postoperative sedation with propofol infusion: haemodynamics and pharmacokinetics.

Authors:  C Sorbara; G Armellin; R Bonato; L Callegher; G Giron
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.